Hainan Huluwa Pharmaceutical Group Co., Ltd.

SSE:605199.SS

9.59 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income 005.13449.71929.03228.99616.13720.80540.5613.79614.2627.71129.914-5.22325.44628.21523.746.42832.56125.51916.99572.9796.70623.76216.882
Depreciation & Amortization 00014.20314.20358.882-26.5713.55413.55412.9512.9512.83712.83713.86613.86610.37110.37143.512-21.59221.592041.505-20.55300
Deferred Income Tax 0000000000000000000000000
Stock Based Compensation 0000000000000000000000000
Change In Working Capital 000-111.5270-265.046289.735-289.7350-251.113254.789-254.7890-62.9481,130.701-1,130.7010-233.292199.643-199.6430-29.02189.86200
Accounts Receivables 000-62.9310-205.084194.181-194.1810-245.052214.526-214.5260-34.1551,127.184-1,127.1840-197.453177.504-177.5040-45.72370.54600
Change In Inventory 000-48.5960-59.96195.554-95.5540-6.06140.264-40.2640-28.7933.517-3.5170-35.83822.139-22.139016.70219.31600
Change In Accounts Payables 0000000000000000000000000
Other Working Capital 0000000000000000000000000
Other Non Cash Items 00-58.9213.808-219.476460.382-373.962213.41-13.554238.163-267.739241.953-29.914146.273-25.446-28.215-23.7-46.428-32.561-25.519-16.995-72.979-6.706-23.762-16.882
Operating Cash Flow 00-53.78739.325-190.444283.214-94.66-41.96640.5613.79614.2627.711-0127.184-47.273100.559-77.986178.387-21.411-61.262-92.415232.283-83.99500
Investing Activities:
Investments In Property Plant And Equipment -36.906-11.484-18.652-34.161-91.934-83.776-102.494-188.804-114.126-291.798-26.4544.138-78.209-24.362-59.624-41.322-12.316-31.614-19.937-1.246-6.618-47.139-2.196-2.887-6.173
Acquisitions Net 00013.6900.050-26.12-8.9760.2490.0090.00100.030.0170.00112.37831.61620.0061.2526.618002.8886.174
Purchases Of Investments 000000000-1100-20-8050-140-5050-29-20-21000-55-195
Sales Maturities Of Investments 00000000011000.45980.459-36.145030.07520.182-20.879-0.01891.126140.49320.266-19.519154.87697.434
Other Investing Activites 0.0070.059013.6900.0500.0340.00100.009-3.7223.269-3.555.24218.63-12.316-51.614-19.937-1.246-6.6180.0020.004-2.887-6.173
Investing Cash Flow -36.9-11.424-18.652-20.472-91.934-83.726-102.494-214.89-123.101-291.549-26.444-19.125-74.482-14.027-68.3827.383-42.071-22.491-48.88569.886-76.125-26.872-21.71196.99-103.739
Financing Activities:
Debt Repayment 39.908-50.381-22.59452.8758.98158.95167.173161.598107.131160.2623.19187.417-89.816139.31882.763-46.83750.4-22.2648.59540.67776.36714.3592.36700
Common Stock Issued 0000000000000000000000000
Common Stock Repurchased 00000000000000000-350000000
Dividends Paid -9.386-8.767-62.651-10.758-9.984-9.502-8.866-7.694-5.501-0.999-4.476-4.449-4.426-4.088-5.225-61.849-2.586-2.672-2.243-1.727-1.354-82.104-1.066-1.638-0.792
Other Financing Activities -0.32130.113-1.127-3.192-0.689-5.896-0.352-2.561-1.424-1.763-0.7891.004-1.004-3.7161.555-6.2992.881-4.246143.263-6.747-6.549-10.431-12.149-13.749-11.982
Financing Cash Flow 30.20370.965-86.37238.925-1.692143.552157.956151.342100.206157.49817.92683.973-95.246131.51379.092-114.98450.695-29.178189.61632.20368.463-78.176-10.848-11.695-12.775
Other Information:
Effect Of Forex Changes On Cash 00000000-158.895413.6891.626-121.611-110.761000000000000
Net Change In Cash -105.324115.331-158.81161.749-284.07343.039-39.198-105.514-141.231293.4347.368-29.052-280.489244.67-36.562-12.043-69.363126.718119.31940.827-100.077127.235-116.55497.594-132.587
Cash At End Of Period 145.841251.166135.835312.916236.868520.938177.899217.097322.611463.841170.407163.039192.091472.58227.91264.472276.515340.877214.15994.8454.013154.08926.854143.40845.814